SelectScience
Join Free
Accelerating Science
NewsLife Sciences

Single Technologies AB raises money for acceleration of DNA sequencing platform

Single Technologies

Single Technologies aims to deliver a paradigm shift in biomolecular analysis with Theta platform

16 Jan 2020
Sophie Ball
Publishing / Media

Industry news

Life science instrumentation and genomics company Single Technologies has announced the completion of a heavily oversubscribed SEK 15M convertible bond issue. JOVB Holding acted as lead investor and the funds will be used to accelerate development of the company’s high throughput DNA sequencing platform Theta.

Single Technologies aims to deliver a paradigm shift in biomolecular analysis with Theta by removing the current limitations of imaging and microfluidics and ensuring true economy of scale in the generation of DNA sequencing data. This would enable the healthcare industry to achieve predictive and prescriptive solutions within DNA data generation and realize the true potential of precision medicine.

The company was founded in 2014 following several years of research into single molecule imaging and biotechnology applications at the Royal Institute of Technology (KTH) in Stockholm, combined with R&D in the fiber optical grating industry by the founders of the fiber optical company, Proximion.

“We are very pleased about the strong interest in the convertible bond issue and it’s a major vote of confidence to have someone like Jens Von Bahr of JOVB Holding, with his strong track record in building companies, investing in our company. Single Technologies’ solution will enable faster and more cost-efficient sequencing of DNA in various types of samples. With the new capital we can further develop our Theta technology and with the next capital raise, which is planned before the summer, we believe we are capitalized to launch a solution that will revolutionize Next Generation Sequencing.” Commented Johan Strömqvist, CEO Single Technologies.

Want more of the latest science news straight to your inbox? Become a SelectScience member for free today>>

Links

Single TechnologiesCompany website

Tags

Next Generation SequencingNext-generation sequencing (NGS), also known as whole-genome sequencing, high-throughput sequencing and massive parallel sequencing, produces and analyses thousands to millions of nucleotide sequences at once. Sequencing systems operate via varying technologies depending on the manufacturer, including sequencing by synthesis, ligation, pyrosequencing, ion semiconductor and single-molecule real-time sequencing. For NGS, library preparation is paramount to successful sequencing. In this section, explore a range of library preparation kits, from targeted, amplicon-based or hybridization-based kits including epigenomic, transcriptomic and genomic workflows to fragmentation kits. Find the best next-generation sequencing products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.DNADeoxyribonucleic Acid (DNA) is the main component of chromosomes and the carrier of genetic information of living organisms. Find out here about PCR, NGS, ChIP-Seq, gel imaging, and many other techniques which can be used for the analysis of DNA.SequencingSequencing refers to determining the order of nucleotides in a DNA or RNA molecule. This process is essential in genomics, diagnostics, and evolutionary biology. Techniques like next-generation sequencing (NGS) and Sanger sequencing provide high-throughput and precise data for analyzing genomes and transcriptomes. Browse our peer-reviewed product directory to find the best sequencing tools and reagents, compare products, check reviews, and get pricing directly from manufacturers.

Related articles

Single Technologies AB raises money for acceleration of DNA sequencing platform